Scale -

  • Revenue is 1.94 Rs Cr; 5 Year CAGR is 42 %
  • Ebitda is 0.21 Rs Cr; 5 Year CAGR is 114 %; Annual Decline is -55 %; Continuous Decline over 3 years
  • PBT is 0.16 Rs Cr; 5 Year CAGR is 114 %; Annual Decline is -55 %; in Bottom Quartile
  • PAT is 0.16 Rs Cr; Annual Decline is -56 %
  • Quarterly Ebitda is N/A Rs Cr; Continuous Decline over 3 Quarters
  • Quarterly Profit is 0.15 Rs Cr; in Bottom Quartile

Profitability -

  • PBDIT Margin is 11.15 %; 5 Year CAGR is 47 %; Annual Decline is -58 %; Continuous Decline over 3 years
  • PAT Margin is 8.19 %; 5 Year CAGR is 306 %; Annual Decline is -59 %

Return -

  • ROCE is 1.85 %; 5 Year CAGR is 58 %; Annual Decline is -56 %; Continuous Decline over 3 years
  • ROA is 0.72 %; Annual Decline is -62 %; Continuous Decline over 3 years
  • ROE is 1.4 %; Annual Decline is -56 %; Continuous Decline over 3 years
  • Asset Turnover is 10 %; Annual Decline is -23 %; Continuous Decline over 3 years

Efficiency -

  • Operating cash flow is -1.84 Rs Cr; Annual Decline is -222 %

Solvancy -

  • Debt/Equity is 0; in Bottom Quartile
  • Total Debt is 0 Rs Cr; in Bottom Quartile
  • Long term Debt is 0 Rs Cr; in Top Quartile
  • Contingent Liabilities is 0 Rs Cr; in Top Quartile

Quality -

  • Operating cashflow/ebitda is -8.76 %; Annual Decline is -373 %; in Bottom Quartile
  • Operating cashflow/PAT is -11.5 %; Annual Decline is -374 %; in Bottom Quartile
  • Current Tax/PAT is 31 %; Annual Growth is 275 %
  • Exceptional Items/PBT is 0 %; in Top Quartile
  • Change in Inventories/Total Expenses is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Total Investment of Approx. USD 6.8 Million in Product Development for Malaria, NTDs and Other Emerging & Re-emerging Infectious Diseases Such as Ebola Disease
Read More
  • Past/current
Who Owns What: The Watermania Waterpark Richmond May Expropriate
Read More
  • Past/current
Rapid Investments Ltd. Estimates – BSE:RAPIDIN
Read More
  • Past/current
5 best short-term investments of 2026
Read More
  • Past/current
Volatility over value: High-beta counters outshine blue-chips as retail investors swarm India’s stock market
Read More
  • Past/current
India Pizza Market Size, Share, Trends and Forecast, 2034
Read More
  • Past/current